Robert R. Smeby

2.6k total citations
70 papers, 1.9k citations indexed

About

Robert R. Smeby is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Organic Chemistry. According to data from OpenAlex, Robert R. Smeby has authored 70 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 17 papers in Cardiology and Cardiovascular Medicine and 12 papers in Organic Chemistry. Recurrent topics in Robert R. Smeby's work include Chemical Synthesis and Analysis (15 papers), Renin-Angiotensin System Studies (15 papers) and Enzyme function and inhibition (11 papers). Robert R. Smeby is often cited by papers focused on Chemical Synthesis and Analysis (15 papers), Renin-Angiotensin System Studies (15 papers) and Enzyme function and inhibition (11 papers). Robert R. Smeby collaborates with scholars based in United States, France and Italy. Robert R. Smeby's co-authors include F. Merlin Bumpus, M. C. Khosla, Subha Sen, Philip A. Khairallah, Irvine H. Page, Serge Fermandjian, Carlos M. Ferrario, Kikuo Arakawa, Karl Lintner and Mahesh C. Khosla and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Robert R. Smeby

69 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert R. Smeby United States 25 1.1k 735 418 229 211 70 1.9k
K. Repke Germany 22 1.3k 1.2× 255 0.3× 145 0.3× 139 0.6× 220 1.0× 127 1.9k
B. Kamber Switzerland 25 1.7k 1.6× 761 1.0× 424 1.0× 592 2.6× 104 0.5× 50 2.3k
Kenneth E. Lentz United States 20 963 0.9× 694 0.9× 316 0.8× 61 0.3× 121 0.6× 31 1.6k
Raymond F. Kauffman United States 24 1.0k 0.9× 275 0.4× 512 1.2× 277 1.2× 254 1.2× 47 2.2k
Donald T. Pals United States 18 690 0.6× 435 0.6× 174 0.4× 388 1.7× 92 0.4× 45 1.3k
Toichi Takenaka Japan 25 781 0.7× 356 0.5× 176 0.4× 237 1.0× 246 1.2× 106 1.8k
Ronald P. Frigon United States 21 833 0.8× 171 0.2× 188 0.4× 161 0.7× 106 0.5× 38 1.8k
Thomas Giller Switzerland 18 1.5k 1.4× 1.7k 2.3× 1.5k 3.5× 172 0.8× 187 0.9× 27 3.4k
Pamela A. Benfield United States 31 2.4k 2.3× 1.7k 2.3× 701 1.7× 379 1.7× 241 1.1× 39 4.0k
Frederic E. Dorer United States 20 893 0.8× 501 0.7× 163 0.4× 49 0.2× 122 0.6× 35 1.4k

Countries citing papers authored by Robert R. Smeby

Since Specialization
Citations

This map shows the geographic impact of Robert R. Smeby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert R. Smeby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert R. Smeby more than expected).

Fields of papers citing papers by Robert R. Smeby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert R. Smeby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert R. Smeby. The network helps show where Robert R. Smeby may publish in the future.

Co-authorship network of co-authors of Robert R. Smeby

This figure shows the co-authorship network connecting the top 25 collaborators of Robert R. Smeby. A scholar is included among the top collaborators of Robert R. Smeby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert R. Smeby. Robert R. Smeby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Senanayake, P., Robert R. Smeby, Almir S. Martins, et al.. (1998). Adrenal, kidney, and heart angiotensins in female murine ren-2 transfected hypertensive rats. Peptides. 19(10). 1685–1694. 29 indexed citations
2.
Smeby, Robert R., et al.. (1988). Measurement of immunoreactive angiotensin peptides in rat tissues: Some pitfalls in angiotensin II analysis. Analytical Biochemistry. 174(1). 80–87. 54 indexed citations
3.
Mikami, Hiroshi, Hidenobu Suzuki, Robert R. Smeby, & Carlos M. Ferrario. (1985). Cerebrospinal fluid angiotensin II immunoreactivity is not derived from the plasma.. Hypertension. 7(1). 65–71. 18 indexed citations
4.
Husain, Ahsan, Robert R. Smeby, Dennis Wilk, Victor J. Dzau, & F. Merlin Bumpus. (1984). Biochemical and Immunological Properties of Dog Brain Isorenin*. Endocrinology. 114(6). 2210–2215. 11 indexed citations
5.
Bumpus, F. Merlin, Ahsan Husain, & Robert R. Smeby. (1984). Extended Forms of Brain Angiotensins and Other Peptide Hormones. Clinical and Experimental Hypertension Part A Theory and Practice. 6(10-11). 2101–2106. 2 indexed citations
6.
7.
Husain, Ahsan, F. Merlin Bumpus, Robert R. Smeby, et al.. (1983). Evidence for the existence of a family of biologically active angiotensin I-like peptides in the dog central nervous system.. Circulation Research. 52(4). 460–464. 16 indexed citations
8.
Sen, S, Robert R. Smeby, F. Merlin Bumpus, & Joseph G. Turcotte. (1979). Role of renin-angiotensin system in chronic renal hypertensive rats.. Hypertension. 1(4). 427–434. 41 indexed citations
9.
Lintner, Karl, Serge Fermandjian, P. Fromageot, et al.. (1977). Circular dichroism studies of angiotensin II and analogs: effects of primary sequence, solvent, and pH on the side-chain conformation. Biochemistry. 16(4). 806–812. 32 indexed citations
10.
Sen, Sudip, Robert R. Smeby, & F. Merlin Bumpus. (1974). Angiotensin Antagonist and Possible Release of Catecholamine. Experimental Biology and Medicine. 147(3). 847–849. 5 indexed citations
11.
Khosla, M. C., et al.. (1972). Synthesis of some analogs of angiotensin II as specific antagonists of the parent hormone. Journal of Medicinal Chemistry. 15(8). 792–795. 62 indexed citations
12.
Price, J. Waide, et al.. (1969). INTERMITTENT CEREBELLAR ATAXIA ASSOCIATED WITH HYPERPYRUVIC ACIDEMIA, HYPERALANINEMIA, AND HYPERALANINURIA. PEDIATRICS. 43(6). 1025–1034. 62 indexed citations
13.
Sen, Subha, et al.. (1967). Isolation of a Phospholipid Renin Inhibitor from Kidney*. Biochemistry. 6(6). 1572–1581. 72 indexed citations
14.
Smeby, Robert R., et al.. (1967). Synthesis of [5-Isoleucine,8-alanine]-angiotensin II by the Solution Method Synthesis and the Solid-Phase Method Synthesis*. Biochemistry. 6(11). 3458–3464. 14 indexed citations
15.
Smeby, Robert R., et al.. (1966). Synthesis of Isoleucine5-Tyrosine8-Angiotensin II and Isoleucine5-Hydroxyproline7-Angiotensin II*. Biochemistry. 5(4). 1224–1229. 2 indexed citations
16.
Bumpus, F. Merlin & Robert R. Smeby. (1962). Importance of Amino Acid Side Groups for Biologic Activity of Angiotensin II. Circulation. 25(1). 183–185. 8 indexed citations
17.
Smeby, Robert R., et al.. (1962). Synthesis of Alanyl-isoleucyl-angiotensin II. Journal of the American Chemical Society. 84(24). 4948–4950. 12 indexed citations
18.
Arakawa, Kikuo, Robert R. Smeby, & F. Merlin Bumpus. (1962). Synthesis of Succinyl1-isoleucyl5-angiotensin II and N-(Poly-O-acetyl-seryl)-isoleucyl5-angiotensin II. Journal of the American Chemical Society. 84(8). 1424–1426. 19 indexed citations
19.
Bumpus, F. Merlin, Philip A. Khairallah, Kikuo Arakawa, Irvine H. Page, & Robert R. Smeby. (1961). The relationship of structure to pressor and oxytocic actions of isoleucine5 angiotensin octapeptide and various analogues. Biochimica et Biophysica Acta. 46(1). 38–44. 55 indexed citations
20.
Free, Helen M., et al.. (1958). A Comparative Study of Qualitative Tests for Ketones in Urine and Serum. Clinical Chemistry. 4(4). 323–330. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K. Repke Breakdown of academic impact, for papers by B. Kamber Breakdown of academic impact, for papers by Kenneth E. Lentz Breakdown of academic impact, for papers by Raymond F. Kauffman Breakdown of academic impact, for papers by Donald T. Pals Breakdown of academic impact, for papers by Toichi Takenaka Breakdown of academic impact, for papers by Ronald P. Frigon Breakdown of academic impact, for papers by Thomas Giller Breakdown of academic impact, for papers by Pamela A. Benfield Breakdown of academic impact, for papers by Frederic E. Dorer
Rankless by CCL
2026